Us Bancorp \De\ Baxter International Inc Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Baxter International Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 117,329 shares of BAX stock, worth $3.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

117,329

Previous 126,178 7.01%

Holding current value

$3.46 Million

Previous $4.22 Million 5.55%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$32.85 - $40.26 $290,689 - $356,260	-8,849 Reduced 7.01%	117,329 $4.45 Million
Q2 2024 Aug 06, 2024	SELL	$32.87 - $43.55 $399,403 - $529,176	-12,151 Reduced 8.78%	126,178 $4.22 Million
Q1 2024 May 07, 2024	SELL	$37.88 - $43.77 $216,370 - $250,014	-5,712 Reduced 3.97%	138,329 $5.91 Million
Q4 2023 Feb 09, 2024	SELL	$31.71 - $38.95 $150,590 - $184,973	-4,749 Reduced 3.19%	144,041 $5.57 Million
Q3 2023 Nov 03, 2023	SELL	$37.32 - $49.29 $543,006 - $717,169	-14,550 Reduced 8.91%	148,790 $5.62 Million
Q2 2023 Aug 09, 2023	SELL	$39.98 - $47.68 $228,405 - $272,395	-5,713 Reduced 3.38%	163,340 $7.44 Million
Q1 2023 May 09, 2023	SELL	$37.58 - $52.57 $475,387 - $665,010	-12,650 Reduced 6.96%	169,053 $6.86 Million
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $1.11 Million - $1.29 Million	22,368 Added 14.04%	181,703 $9.26 Million
Q3 2022 Oct 27, 2022	SELL	$53.86 - $66.8 $1.44 Million - $1.78 Million	-26,648 Reduced 14.33%	159,335 $8.58 Million
Q2 2022 Aug 01, 2022	SELL	$63.83 - $80.0 $457,214 - $573,040	-7,163 Reduced 3.71%	185,983 $11.9 Million
Q1 2022 May 11, 2022	SELL	$76.85 - $89.45 $380,100 - $442,419	-4,946 Reduced 2.5%	193,146 $15 Million
Q4 2021 Feb 11, 2022	SELL	$74.57 - $87.19 $324,379 - $379,276	-4,350 Reduced 2.15%	198,092 $17 Million
Q3 2021 Nov 10, 2021	SELL	$73.77 - $83.61 $404,923 - $458,935	-5,489 Reduced 2.64%	202,442 $16.3 Million
Q2 2021 Aug 05, 2021	SELL	$80.5 - $88.01 $1.54 Million - $1.68 Million	-19,096 Reduced 8.41%	207,931 $16.7 Million
Q1 2021 Apr 28, 2021	SELL	$76.38 - $86.03 $1.35 Million - $1.52 Million	-17,631 Reduced 7.21%	227,027 $19.1 Million
Q4 2020 Feb 04, 2021	SELL	$75.39 - $82.36 $664,562 - $726,003	-8,815 Reduced 3.48%	244,658 $19.6 Million
Q3 2020 Nov 10, 2020	SELL	$78.33 - $90.73 $393,686 - $456,008	-5,026 Reduced 1.94%	253,473 $20.4 Million
Q2 2020 Aug 07, 2020	SELL	$78.66 - $94.14 $415,796 - $497,624	-5,286 Reduced 2.0%	258,499 $22.3 Million
Q1 2020 May 13, 2020	SELL	$71.57 - $93.3 $967,554 - $1.26 Million	-13,519 Reduced 4.88%	263,785 $21.4 Million
Q4 2019 Feb 04, 2020	SELL	$76.7 - $88.45 $4.47 Million - $5.15 Million	-58,231 Reduced 17.35%	277,304 $23.2 Million
Q3 2019 Nov 08, 2019	SELL	$81.4 - $89.78 $370,939 - $409,127	-4,557 Reduced 1.34%	335,535 $29.3 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $426,172 - $478,225	-5,803 Reduced 1.68%	340,092 $27.9 Million
Q1 2019 May 08, 2019	SELL	$64.48 - $81.31 $249,150 - $314,181	-3,864 Reduced 1.1%	345,895 $28.1 Million
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $2.47 Million - $3.13 Million	-40,229 Reduced 10.32%	349,759 $23 Million
Q3 2018 Nov 01, 2018	SELL	$70.71 - $77.75 $58,265 - $64,066	-824 Reduced 0.21%	389,988 $30.1 Million
Q2 2018 Aug 08, 2018	BUY	$63.43 - $75.41 $62,097 - $73,826	979 Added 0.25%	390,812 $28.9 Million
Q1 2018 May 08, 2018	SELL	$62.56 - $72.26 $114,297 - $132,019	-1,827 Reduced 0.47%	389,833 $25.4 Million
Q4 2017 Feb 02, 2018	BUY	$61.45 - $66.05 $281,133 - $302,178	4,575 Added 1.18%	391,660 $25.3 Million
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $23 Million - $25 Million	387,085	387,085 $24.3 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account